Saskia de Wildt

Saskia de Wildt is a researcher at Erasmus MC in the Department of Neonatal and Pediatric Intensive Care. She is actively contributing to clinical pharmacology and pediatric medicine, with a strong focus on pharmacokinetics and individualized drug therapy in children and neonates.

Her research interests span pharmacokinetics, physiologically based pharmacokinetic modeling, pharmacotherapy in pediatrics, off-label drug use, and model-informed precision dosing. Her work aims to improve drug safety and efficacy in vulnerable pediatric populations, particularly in intensive care settings.

The recent publications highlight a strong trend in optimizing drug dosing during pregnancy and in critically ill children, leveraging computational modeling and systematic evidence synthesis. Her work bridges pharmacology, neonatology, and clinical implementation science.

She has contributed to influential publications such as The Lancet Child & Adolescent Health and Clinical Pharmacology & Therapeutics, indicating recognition in high-impact journals. Her research has been cited in Scopus and picked up by news outlets and academic platforms like Mendeley and X.

Saskia de Wildt has supervised 10 research projects, reflecting her role in mentoring the next generation of researchers in pediatric pharmacology. Although no specific grants are mentioned, her extensive output suggests active grant funding and collaborative research.

She is affiliated with a leading research network in pediatric and neonatal intensive care at Erasmus MC, working in a multidisciplinary environment focused on advancing neonatal pharmacotherapy and critical care practices.